Pharmacological treatment after acute coronary syndrome: Baseline clinical characteristics and gender differences in a population-based cohort study

2014 Khan, 2020, Global epidemiology of ischemic heart disease: results from the global burden of disease study, Cureus, 12, e9349 Mensah, 2017, Decline in cardiovascular mortality, Circ Res, 120, 366, 10.1161/CIRCRESAHA.116.309115 Crowley, 2015, Medication non-adherence after myocardial infarction: an exploration of modifying factors, J Gen Intern Med, 30, 83, 10.1007/s11606-014-3072-x Sanfélix-Gimeno, 2013, Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain, J Manag Care Pharm, 19, 247, 10.18553/jmcp.2013.19.3.247 Bansilal, 2016, Assessing the impact of medication adherence on long-term cardiovascular outcomes, J Am Coll Cardiol, 68, 789, 10.1016/j.jacc.2016.06.005 Banerjee, 2016, Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review, Open Hear, 3, e000438, 10.1136/openhrt-2016-000438 Ibanez, 2018, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 39, 119, 10.1093/eurheartj/ehx393 Roffi, 2015, Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST, Rev Española Cardiol, 68, 1125e1, 10.1016/j.recesp.2015.10.012 National Institute for Health and Care Excellence (NICE), 2013 Amsterdam, 2014, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary, J Am Coll Cardiol, 64, 2645, 10.1016/j.jacc.2014.09.016 Ghimire, 2014, Guidelines in review: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, J Nucl Cardiol, 21, 190, 10.1007/s12350-013-9808-x Lafeber, 2013, The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease, Am Heart J, 166, 282, 10.1016/j.ahj.2013.04.011 García-García, 2014, Sex-based differences in clinical features management, and 28-day and 7-year prognosis of first acute myocardial infarction. RESCATE II study, Rev Esp Cardiol, 67, 28, 10.1016/j.recesp.2013.06.027 Lahoz, 2009, Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease, Int J Cardiol, 133, 336, 10.1016/j.ijcard.2007.12.115 Plaza-Martín, 2019, Contemporary differences between men and women with acute coronary syndromes: CIAM multicenter registry, J Cardiovasc Med (Hagerstown), 20, 525, 10.2459/JCM.0000000000000812 ten Haaf, 2019, Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands, Netherlands Hear J, 27, 263, 10.1007/s12471-019-1271-0 Giner-Soriano, 2018, Impact of medication adherence on mortality and cardiovascular morbidity: protocol for a population-based cohort study, JMIR Res Protoc, 7, e73, 10.2196/resprot.8121 2020, Information system for research in Primary Care, SIDIAP WHO. ICD-10 Version: 2016 [Internet]. International Statistical Classification of diseases and Related Health Problems 10th Revision. s.f. 2019, ATC/DDD Index, 2019 CatSalut, 2019, Servei Català de la Salut, Conjunt mínim bàsic de dades (CMBD) MSSSI M de SSS e I. Clasificación internacional de enfermedades 9a revisión, modificación clínica (eCIE9MC). eCIE9MC. 2014. Domínguez-Berjón, 2008, Construcción de un índice de privación a partir de datos censales en grandes ciudades españolas (Proyecto MEDEA), Gac Sanit, 22, 179, 10.1157/13123961 Caro-Mendivelso, 2015, Associations between socioeconomic index and mortality in rural and urban small geographic areas of Catalonia Spain: ecological study, J Epidemiol Res, 2, 80, 10.5430/jer.v2n1p80 Ribas, 2017, Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion, BMC Cardiovasc Disord, 17, 54, 10.1186/s12872-017-0493-6 Valero-Masa, 2017, Sex differences in acute myocardial infarction: is it only the age?, Int J Cardiol, 231, 36, 10.1016/j.ijcard.2016.11.010 Plaza-Martín, 2019, Contemporary differences between men and women with acute coronary syndromes: CIAM multicenter registry, J Cardiovasc Med, 20, 525, 10.2459/JCM.0000000000000812 Wilkinson, 2019, Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study, Heart, 105, 516, 10.1136/heartjnl-2018-313959 Zagnoni, 2017, Sex differences in the management of acute coronary syndromes in Italy: data from the MANTRA registry, J Cardiovasc Med, 18, 178, 10.2459/JCM.0000000000000390 Catapano, 2017, 2016 ESC/EAS guidelines for the management of dyslipidemias, Rev Esp Cardiol, 70 Lafeber, 2013, The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease, Am Heart J, 166, 282, 10.1016/j.ahj.2013.04.011 Timmis, 2018, European Society of Cardiology: cardiovascular disease statistics 2017, Eur Heart J, 39, 508, 10.1093/eurheartj/ehx628 Hao, 2019, Sex differences in in-hospital management and outcomes of patients with acute coronary syndrome, Circulation, 139, 1776, 10.1161/CIRCULATIONAHA.118.037655 Lee, 2008, Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge, J Manag Care Pharm, 14, 271, 10.18553/jmcp.2008.14.3.271 Cherubini, 2012, Underprescription of beneficial medicines in older people: causes, consequences and prevention, Drugs Aging, 29, 463, 10.2165/11631750-000000000-00000 Vasiljevic- Pokrajcic, 2016, Sex and age differences and outcomes in acute coronary syndromes, Int J Cardiol, 217, S27, 10.1016/j.ijcard.2016.06.217 Vogel, 2016, Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation, Eur Hear J Acute Cardiovasc care, 5, 347, 10.1177/2048872615585514 Cenko, 2018, Sex differences in outcomes after STEMI: effect modification by treatment strategy and age, JAMA Intern Med, 178, 632, 10.1001/jamainternmed.2018.0514 Zeymer, 2011, Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker Support for a polypill approach, Curr Med Res Opin, 27, 1563, 10.1185/03007995.2011.590969 Pereira, 2014, Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study, Eur J Prev Cardiol, 21, 1401, 10.1177/2047487313494580 Wilkinson, 2019, Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study Coronary artery disease, Heart, 105, 516, 10.1136/heartjnl-2018-313959 Chow, 2019, Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study, Heart Asia, 11 Saunderson, 2014, Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges, Age Ageing, 10.1093/ageing/afu034 Ramos, 2017, Validity for use in research on vascular diseases of the SIDIAP (information system for the development of research in primary care): the EMMA study, Rev Esp Cardiol (Engl Ed), 65, 29, 10.1016/j.recesp.2011.07.017 Vinagre, 2012, Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain), Diabetes Care, 35, 774, 10.2337/dc11-1679 Bolíbar, 2012, Base de datos SIDIAP: la historia clínica informatizada de Atención Primaria como fuente de información para la investigación epidemiológica, Med Clin (Barc), 138, 617, 10.1016/j.medcli.2012.01.020